
The Ins and Outs of Incorporating Patient Centricity in Drug Development
ByParexel
Published: | Updated:


• Navigating global regulatory complexities requires simplification. • Technology can optimize daily activities and overall compliance. • Increasing transparency with real-time data provides more accurate insights.


In today’s evolving, value-based environment for specialty drugs, high-touch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery. Using gene therapy as a specific example, this white paper will discuss many of the high-touch services that can help enhance patient outcomes.
